Rachel Lloyd

Dr. Rachel Lloyd

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
RLRachel Lloyd
Rachel Lloyd
SPSarah Pirikahu
Sarah Pirikahu
JWJane Walter
Jane Walter
GCGemma Cadby
Gemma Cadby
EDEllie Darcey
Ellie Darcey
JSJennifer Stone
Jennifer Stone
Background: Breast density is a strong and potentially modifiable breast cancer risk factor. Almost everything we know about breast density has been derived from mammography, and therefore, very little is known about breast density in younger women aged <40. This study examines the acceptability and performance of two alternative breast density measures, Optical Breast Spectroscopy (OBS) and Dual X-ray Absorptiometry (DXA), in women aged 18–40. Methods: Breast tissue composition (percent water, collagen, and lipid content) was measured in 539 women aged 18–40 using OBS. For a subset of 169 women, breast density was also measured via DXA (percent fibroglandular dense volume (%FGV), absolute dense volume (FGV), and non-dense volume (NFGV)). Acceptability of the measurement procedures was assessed using an adapted validated questionnaire. Performance was assessed by examining the correlation and agreement between the measures and their associations with known determinants of mammographic breast density. Results: Over 93% of participants deemed OBS and DXA to be acceptable. The correlation between OBS-%water + collagen and %FGV was 0.48. Age and BMI were inversely associated with OBS-%water + collagen and %FGV and positively associated with OBS-%lipid and NFGV. Conclusions: OBS and DXA provide acceptable and viable alternative methods to measure breast density in younger women aged 18–40 years.

30 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
RLRachel Lloyd
Rachel Lloyd
SPSarah Pirikahu
Sarah Pirikahu
JWJane Walter
Jane Walter
GCGemma Cadby
Gemma Cadby
NWNicole Warrington
Nicole Warrington
JSJennifer Stone
Jennifer Stone
Breast density is a strong intermediate endpoint to investigate the association between early-life exposures and breast cancer risk. This study investigates the association between early-life growth and breast density in young adult women measured using Optical Breast Spectroscopy (OBS) and Dual X-ray Absorptiometry (DXA). OBS measurements were obtained for 536 female Raine Cohort Study participants at ages 27–28, with 268 completing DXA measurements. Participants with three or more height and weight measurements from ages 8 to 22 were used to generate linear growth curves for height, weight and body mass index (BMI) using SITAR modelling. Three growth parameters (size, velocity and timing) were examined for association with breast density measures, adjusting for potential confounders. Women who reached their peak height rapidly (velocity) and later in adolescence (timing) had lower OBS-breast density. Overall, women who were taller (size) had higher OBS-breast density. For weight, women who grew quickly (velocity) and later in adolescence (timing) had higher absolute DXA-breast density. Overall, weight (size) was also inversely associated with absolute DXA-breast density, as was BMI. These findings provide new evidence that adolescent growth is associated with breast density measures in young adult women, suggesting potential mediation pathways for breast cancer risk in later life.

1 April 2022 in Review of Scientific Instruments
Verified
Journal Article
Closed access
PDF file
RLRachel Lloyd
Rachel Lloyd
JWJane Walter
Jane Walter
SPSarah Pirikahu
Sarah Pirikahu
GCGemma Cadby
Gemma Cadby
MHMartha Hickey
Martha Hickey
JSJennifer Stone
Jennifer Stone
Mammographic breast density is a strong breast cancer risk factor, and its routine clinical measurement could potentially be used to identify women at higher risk of breast cancer and/or monitor primary prevention strategies. Previous reports of optical breast spectroscopy (OBS), a novel approach to measuring breast density, demonstrated that it is safe (no ionizing radiation), portable, low-cost, and does not require image interpretation but have been limited to small, single-center studies. Reference measurements taken on a phantom breast prior to and after each woman’s OBS assessment are required for the calibration of the system transfer function as a part of processing participant data. To inform the validity of participant data, a detailed description of the reference measurements and a repeatability analysis of these measurements taken before and after participant assessment is presented. Reference measurements for OBS from 539 women aged 18–40 years were obtained as a part of a high-throughput epidemiological pilot study. Of these, measurements from 20 women with no useable data due to device failure (3.7%) were excluded and from another 12 women due to user error. The intra-class correlation (ICC) within complete pairs of reference data (taken before and after assessment) was high (all ICC > 0.84). The analysis presented here confirms the OBS participant data as valid for use in ongoing epidemiological research, providing further supporting evidence of OBS as a measure of breast density. A novel method of measuring breast density is needed to bridge large gaps in the knowledge of breast density in younger women and its relation to later-life breast cancer risk.

26 October 2026 in Journal of Developmental Origins of Health and Disease
Verified
Journal Article
Open access
PDF file
RLRachel Lloyd
Rachel Lloyd
BPBlagica Penova-Veselinovic
Blagica Penova-Veselinovic
SOSlaine O’HAlloran
Slaine O’HAlloran
SASaniya Abdul
Saniya Abdul
ADAlex D’VAuz
Alex D’VAuz
PMPhillip Melton
Phillip Melton
The Developmental Origins of Health and Disease (DOHaD) framework has transformed understanding of how early-life exposures shape health across the life course, yet populations from Oceania remain underrepresented in this research. The Raine Study is a globally unique, multigenerational longitudinal pregnancy cohort established in Western Australia, one of the world’s most geographically isolated regions. The study recruited 2900 pregnant women (Generation1) in 1989, which resulted in 2868 live births forming Generation 2, and is now currently recruiting Generation 3 (the children of Generation 2). This paper describes the evolution of the Raine Study from its origins as a pregnancy cohort grounded in DOHaD to a comprehensive life-course and multigenerational research resource. This resource has led to key research findings that have informed international clinical guidelines and national and state health policies across areas including prenatal development and care safety, neurodevelopment, cardiometabolic health, obesity, liver disease, physical activity, mental health, sedentary behaviour, sleep, and assisted reproductive technologies. Central to the Raine Study’s success is a longstanding commitment to participant partnership and engagement, resulting in exceptional retention and strong consumer involvement in governance and research prioritisation. The Raine Study demonstrates the critical value of well-characterised, place-based cohorts for advancing DOHaD and life-course science and provides a globally significant resource to inform prevention strategies, precision medicine, and public health policy across generations.